Local not-for-profit with U of A roots runs cancer clinical trials around the world
Gillian Rutherford - 30 March 2021
Building on game-changing breast cancer trials, TRIO now testing drugs for breast, lung, ovarian, liver and gastrointestinal cancer.
CEO Launa Aspeslet (Pharmacy graduate) and oncology researcher John Mackey (FoMD) and data analyst Ana Anoveros (ALES graduate) explain how Translational Research in Oncology (TRIO) is building on game-changing breast cancer trials and now testing drugs for breast, lung, ovarian, liver and gastrointestinal cancer.